Global Blood Therapeutics (GBT) Short Interest Ratio & Short Volume → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free GBT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Global Blood Therapeutics Short Interest DataCurrent Short Volume7,280,000 sharesPrevious Short Volume6,890,000 sharesChange Vs. Previous Month+5.66%Dollar Volume Sold Short$493.44 millionShort Interest Ratio / Days to Cover2.1Last Record DateSeptember 15, 2022Outstanding Shares67,476,000 sharesPercentage of Shares Shorted10.79%Today's Trading Volume74 sharesAverage Trading Volume2,065,836 sharesToday's Volume Vs. Average0% Short Selling Global Blood Therapeutics ? Sign up to receive the latest short interest report for Global Blood Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGBT Short Interest Over TimeGBT Days to Cover Over TimeGBT Percentage of Float Shorted Over Time Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> Global Blood Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20227,280,000 shares $493.44 million +5.7%N/A2.1 $67.78 8/31/20226,890,000 shares $467.83 million +18.8%N/A2.1 $67.90 8/15/20225,800,000 shares $388.83 million -38.1%N/A2 $67.04 7/31/20229,370,000 shares $306.59 million +1.5%15.2%3.9 $32.72 7/15/20229,230,000 shares $332.19 million -6.3%15.0%6.1 $35.99 6/30/20229,850,000 shares $314.71 million -7.5%16.0%6.5 $31.95 Get the Latest News and Ratings for GBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global Blood Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/15/202210,650,000 shares $246.76 million -1.6%17.3%7.6 $23.17 5/31/202210,820,000 shares $269.85 million -7.8%17.5%8.8 $24.94 5/15/202211,730,000 shares $0.00 +6.4%19.0%9.9 $0.00 4/30/202211,030,000 shares $338.62 million +5.5%N/A9.7 $30.70 4/15/202210,460,000 shares $370.70 million -3.7%N/A9.4 $35.44 3/31/202210,860,000 shares $376.19 million No ChangeN/A9.3 $34.64 3/15/202210,860,000 shares $313.31 million -3.8%N/A8.8 $28.85 2/28/202211,290,000 shares $340.96 million +9.4%N/A7.1 $30.20 2/15/202210,320,000 shares $330.55 million +5.0%N/A6.5 $32.03 1/31/20229,830,000 shares $283.60 million +2.6%N/A6.3 $28.85 1/15/20229,580,000 shares $277.72 million +11.4%N/A6 $28.99 12/31/20218,600,000 shares $251.72 million +20.3%N/A5.7 $29.27 12/15/20217,150,000 shares $201.63 million +19.4%N/A4.6 $28.20 11/30/20215,990,000 shares $169.28 million +3.5%N/A5 $28.26 11/15/20215,790,000 shares $196.11 million -12.5%N/A4.9 $33.87 10/29/20216,620,000 shares $241.76 million +6.8%10.9%5.3 $36.52 10/15/20216,200,000 shares $189.22 million -6.3%10.2%5.3 $30.52 9/30/20216,620,000 shares $168.68 million -28.9%10.9%5.4 $25.48 9/15/20219,310,000 shares $241.78 million -12.3%15.3%7.1 $25.97 8/31/202110,610,000 shares $304.40 million -9.9%17.5%8.2 $28.69 8/13/202111,780,000 shares $326.31 million -0.3%19.4%9.5 $27.70 7/30/202111,810,000 shares $322.77 million -3.0%19.4%9.9 $27.33 7/15/202112,170,000 shares $398.32 million -2.5%20.1%11 $32.73 6/30/202112,480,000 shares $437.05 million +7.7%20.6%11.9 $35.02 6/15/202111,590,000 shares $458.38 million +0.8%19.1%13.8 $39.55 5/28/202111,500,000 shares $441.95 million -4.7%19.0%14.4 $38.43 5/14/202112,070,000 shares $428.00 million +4.1%N/A13.4 $35.46 4/30/202111,600,000 shares $484.76 million -2.6%N/A12.8 $41.79 4/15/202111,910,000 shares $493.91 million +3.8%N/A12.7 $41.47 3/31/202111,480,000 shares $467.81 million -2.6%N/A11.5 $40.75 3/15/202111,780,000 shares $518.56 million -0.7%N/A11.8 $44.02 2/26/202111,860,000 shares $515.91 million +2.8%N/A10.3 $43.50 2/12/202111,540,000 shares $548.61 million +1.6%N/A10.5 $47.54 1/29/202111,360,000 shares $549.14 million +0.9%N/A7.5 $48.34Altcoin FRENZY Alert… (Ad)Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) GBT Short Interest - Frequently Asked Questions What is Global Blood Therapeutics' current short interest? Short interest is the volume of Global Blood Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 7,280,000 shares of GBT short. Learn More on Global Blood Therapeutics' current short interest. What is a good short interest ratio for Global Blood Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GBT shares currently have a short interest ratio of 2.0. Learn More on Global Blood Therapeutics's short interest ratio. Is Global Blood Therapeutics' short interest increasing or decreasing? Global Blood Therapeutics saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 7,280,000 shares, an increase of 5.7% from the previous total of 6,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Global Blood Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Global Blood Therapeutics: Organon & Co. (3.97%), Biohaven Ltd. (10.58%), Alkermes plc (8.43%), Nuvalent, Inc. (22.77%), Madrigal Pharmaceuticals, Inc. (20.17%), Perrigo Company plc (2.76%), BridgeBio Pharma, Inc. (9.82%), Insmed Incorporated (5.95%), Blueprint Medicines Co. (8.42%), Ultragenyx Pharmaceutical Inc. (4.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.11 billion), Canadian Natural Resources Limited ($3.64 billion), Charter Communications, Inc. ($3.15 billion), Lucid Group, Inc. ($2.09 billion), Chesapeake Energy Co. ($2.02 billion), Coinbase Global, Inc. ($2.01 billion), T. Rowe Price Group, Inc. ($1.92 billion), Plug Power Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.71 billion), and Williams-Sonoma, Inc. ($1.59 billion). View all of the most shorted stocks. What does it mean to sell short Global Blood Therapeutics stock? Short selling GBT is an investing strategy that aims to generate trading profit from Global Blood Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Global Blood Therapeutics? A short squeeze for Global Blood Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GBT, which in turn drives the price of the stock up even further. How often is Global Blood Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GBT, twice per month. The most recent reporting period available is September, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Organon & Co. Short Interest Data Biohaven Short Interest Data Alkermes Short Interest Data Nuvalent Short Interest Data Madrigal Pharmaceuticals Short Interest Data Perrigo Short Interest Data BridgeBio Pharma Short Interest Data Insmed Short Interest Data Blueprint Medicines Short Interest Data Ultragenyx Pharmaceutical Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GBT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics